Category
Hemodynamics & Fluid Resuscitation
Journal
NEJM Evidence
Takeaway
Subcutaneous zalunfiban at first medical contact improved a hierarchical composite in STEMI (OR 0.79).
Verdict
Positive
Year
2025
NEJM Evidence
Subcutaneous zalunfiban at first medical contact improved a hierarchical composite in STEMI (OR 0.79).